DSC Advisors’s Merck MRK Stock Holding History

DSC Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-104,800	Closed	-$81K	–	78
2014 Q1	$81K	Buy	+104,800	New	+$5.43M	0.04%	59

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DSC Advisors's MRK Position: Q4 2022 in Review

DSC Advisors sold out of Merck (MRK) in Q4 2022, closing a stake of 3,003 shares — an estimated $259K sold.

DSC Advisors first reported a position in MRK in Q2 2013 and held it in 13 quarters. The position peaked at $3.79M in Q3 2014. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

DSC Advisors reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
DSC Advisors sold 3,003 Merck shares in Q4 2022, an estimated $259K.
DSC Advisors first reported a position in Merck in Q2 2013 and held it in 13 quarters.
DSC Advisors's Merck position peaked at $3.79M in Q3 2014.
3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on DSC Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.